Successful Eradication of Relapsed Primary Effusion Lymphoma with High-Dose Chemotherapy and Autologous Stem Cell Transplantation in a Patient Seronegative for Human Immunodeficiency Virus
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-05-15
著者
-
Han Seung-hyo
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Park Hee-sook
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Park Sung-kyu
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Hong Dae-sik
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Bae Sang-byung
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Lee Nam-su
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
WON Jong-Ho
Department of Internal Medicine, Soon Chun Hyang University College of Medicine
-
KIM Chan-Kyu
Department of Internal Medicine, Soon Chun Hyang University College of Medicine
-
LEE Kyu-Taeg
Department of Internal Medicine, Soon Chun Hyang University College of Medicine
-
LEE Dong-Wha
Department of Pathology, Soon Chun Hyang University College of Medicine
-
Won Jong-ho
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Lee Dong-wha
Department Of Pathology Soon Chun Hyang University College Of Medicine
-
Kim Chan-kyu
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
-
Lee Kyu-taeg
Department Of Internal Medicine Soon Chun Hyang University College Of Medicine
関連論文
- Successful Eradication of Relapsed Primary Effusion Lymphoma with High-Dose Chemotherapy and Autologous Stem Cell Transplantation in a Patient Seronegative for Human Immunodeficiency Virus
- Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma : organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study
- Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab : Consortium for Improving Survival of Lymphoma (CISL) study